BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has successfully completed production of its largest order...
Company Treasury Exceeds $12 Million with Recently Implemented Active Yield Generation Strategy Provides Nasdaq Listing Status Update
Patent Covers the Composition of LineaRx's Proprietary Linea™ RNA Polymerase (RNAP), a Core Technology Empowering the Linea™ IVT Platform
Provides Updated on BNB Token Holdings and Operating Company Performance
ORLANDO, FLORIDA / ACCESS Newswire / February 6, 2026 / RedChip Companies will air interviews with OBOOK Holdings Inc. (NASDAQ:OWLS) ("OwlTing") and BNB Plus Corp. (Nasdaq:BNBX) on the RedChip Small Stocks,...
ORLANDO, FLORIDA / ACCESS Newswire / January 28, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming...
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Acceleration of Multi-Year Customer Agreement Represents Largest LineaDNA Order in Company History Company Expects to Ship over $1.5M of LineaDNA in 1HCY2026